Benjamin F. Edwards & Company, Inc. Lannett CO Inc Transaction History

Benjamin F. Edwards & Company, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 31, 2019	SELL	$3.43 - $6.19 $10,290 - $18,570	-3,000 Closed	0 $0
Q1 2018 Apr 17, 2018	BUY	$14.7 - $24.95 $44,100 - $74,850	3,000 New	3,000 $48,000
Q4 2017 Jan 17, 2018	SELL	$19.9 - $29.25 $79,600 - $117,000	-4,000 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$15.1 - $19.25 $60,400 - $77,000	4,000	4,000 $74,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.